Credit: Shutterstock
January 27, 2025 11:00 AM ESTUpdated 47 minutes ago
Pharma
FDA+
In Focus
Law

Trump blog: Top HHS spokesper­son re­signs with­in weeks of be­ing sworn in

ENDPOINTS

Tom Cor­ry, as­sis­tant sec­re­tary of pub­lic af­fairs at HHS, re­signed on Fri­day “ef­fec­tive im­me­di­ate­ly,” ac­cord­ing to a LinkedIn …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director Oligonucleotide R&D

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Af­ter Phase 3 de­pres­sion set­back, Neumo­ra paus­es two tri­als to make changes, scraps an­oth­er

Ab­b­Vie fi­nal­ly en­ters obe­si­ty race with $350M up­front for Gubra’s amylin

AD­Cs from a decade-old Sin­ga­pore biotech find new life with $187M

No­vo Nordisk signs $354M part­ner­ship with AI-guid­ed biotech for ‘risky’ new meta­bol­ic mech­a­nisms

Pro­tag­o­nist, Takeda's prof­it shar­ing deal un­der spot­light af­ter Phase 3 blood dis­or­der tri­al win

sponsored

The per­fect storm: Why every­thing is in place for 2025 to be the year of GxP AI

A service from the Financial Times